Our website uses cookies so that we can make your shopping experience as simple and enjoyable as possible. You can read all about how we use them in our Cookies Policy. To accept this you don't need to do anything just carry on shopping, have fun. Close

Treat 1 - Spend £50...Save £5:TREAT5CD

NiQuitin 8 Week Programme For Light Smokers

6 Boxes of 14mg (7), 2 Boxes of 7mg (7)
In Stock
Delivery information Product #0009169

Please note images are for illustration purposes and may differ from the product(s) you receive

NiQuitin 8 Week Programme For Light Smokers is designed for smokers who smoke less than 10 cigarettes per day. This dedicated programme contains enough patches to complete the 8 week course.

NiQuitin 8 Week Programme For Light Smokers is designed to help support smoking cessation for smokers of less than 10 cigarettes a day. This pack gives you an 8 week’s supply of NiQuitin CQ Clear Patches.

In this pack you will get:

  • 6 packs of Step 2 NiQuitin CQ Patches
  • 2 packs of Step 3 NiQuitin CQ Patches

How to use it

The original NiQuitin programme is designed with 3 steps to help you quit smoking; however, NiQuitin 8 Week Programme is designed for light smokers of less than 10 cigarettes, and starts from Step 2.

Step 2: NiQuitin CQ Clear 14mg for 6 weeks
Step 3: NiQuitin CQ Clear 7mg for 2 weeks

Each step of the 8 week plan, has its own strength nicotine patch that is designed to give you just the right amount of nicotine replacement as you transition from step to step.

Precautions before using Niquitin Cq 8 Week Program For Light Smokers:

  • The risks associated with the use of NRT are substantially outweighed in virtually all circumstances by the well-established dangers of continued smoking. Patients hospitalised for MI, severe dysrhythmia or CVA who are considered to be haemodynamically unstable should be encouraged to stop smoking with non-pharmacological interventions. If this fails, NiQuitin Clear patches may be considered, but as data on safety in this patient group are limited, initiation should only be under medical supervision. Once patients are discharged from hospital, they can use NRT as normal.
  • Diabetes Mellitus: Patients with diabetes mellitus should be advised to monitor their blood sugar levels more closely than usual when NRT is initiated as catecholamines released by nicotine can affect carbohydrate metabolism.
  • Allergic reactions: Susceptibility to angioedema and urticaria.
  • Atopicor eczematous dermatitis (due to localised patch sensitivity): In the case of severe or persistent local reactions at the site of application (e.g. severe erythema, pruritus or oedema) or a generalised skin reaction (e.g. urticaria, hives or generalised skin rashes), users should be instructed to discontinue use of NiQuitin Clear and contact their physician.
  • Contact sensitisation: Patients with contact sensitisation should be cautioned that a serious reaction could occur from exposure to other nicotine-containing products or smoking.
  • Renal and hepatic impairment: Use with caution in patients with moderate to severe hepatic impairment and/or severe renal impairment as the clearance of nicotine or its metabolites may be decreased with the potential for increased adverse effects.
  • Phaeochromocytoma and uncontrolled hyperthyroidism: Use with caution in patients with uncontrolled hyperthyroidism or phaeochromocytoma as nicotine causes release of catecholamines.
  • Danger in small children: Doses of nicotine tolerated by adult and adolescent smokers can produce severe toxicity in small children that may be fatal. Products containing nicotine should not be left where they may be misused, handled or ingested by children. The patches should be folded in half with the adhesive side innermost and disposed of with care.
  • Stopping smoking: Polycyclic aromatic hydrocarbons in tobacco smoke induce the metabolism of drugs catalysed by CYP 1A2 (and possibly by CYP 1A1). When a smoker stops this may result in a slower metabolism and a consequent rise in blood levels of such drugs.
  • Transferred dependence: Transferred dependence is rare and is both less harmful and easier to break than smoking dependence.
  • Safety on handling: NiQuitin Clear is potentially a dermal irritant and can cause contact sensitisation. Care should be taken during handling and in particular contact with the eyes and nose avoided. After handling, wash hands with water alone as soap may increase nicotine absorption.

Caution before using Niquitin Cq 8 Week Program For Heavy Smokers:

Nicotine Replacement Therapy may cause adverse reactions similar to those associated with nicotine administered by other means, including smoking. These may be attributable to the pharmacological effects of nicotine, some of which are dose dependent. At recommended doses NiQuitin Clear patches have not been found to cause any serious adverse effects. Excessive use of NiQuitin Clear patches by those who have not been in the habit of inhaling tobacco smoke could possibly lead to nausea, faintness or headaches.

Subjects quitting smoking by any means could expect to suffer from asthenia, headache, dizziness, sleep disturbance, coughing or influenza-like illness. Certain symptoms which have been reported such as depression, irritability, nervousness, restlessness, mood lability, anxiety, drowsiness, impaired concentration and insomnia may be related to withdrawal symptoms associated with smoking cessation.

Niquitin Cq 8 Week Program For Light Smokers contains:

  • Step 2: 78mg of Nicotine delivering 14mg per 24 hours. 
  • Step 3: 36mg of Nicotine delivering 7mg per 24 hours.
Add Your Review
Value for money
Overall rating
Share Your Experience (optional) *required fields
Your winning voucher will be sent to this email address

Sign up to our newsletter and get the latest deals, exclusive offers, health advice from our online doctor and much more.

* Terms and conditions apply